Finding accredited CPD
A series of videos presented by Professor Michael Dickinson discussing CAR T-Cell Therapy: Axicabtagene Ciloleucel for Second-Line Treatment of Relapsed or Refractory Large B-Cell Lymphoma.
In this video, Professor Dickinson presents on the Role of Axi-cel in second-line treatment, eligibility criteria, choosing second-line Axi-cel and safety data.
Presented by Professor Michael Dickinson MBBS, D Med Sc, FRACP, FRCPA.
This activity is accepted by CPD Home as a Domain 1: Educational Activity in alignment with the CPD Home Program Guide.
Disclaimer: Please note, once you click 'Enrol now' you will be leaving the AMA’s CPD Home website and entering a third-party website.
*Medical Board of Australia’s (MBA)’s revised Registration Standard: Continuing professional development (the Standard)
